Drug Screening Methods (Preclinical Evaluation of New Drugs), 2/E

1. Newer Tools for Drug Screening; 2. High Throughput Screening for Drug Discovery; 3. Models for Studying Stem Cell Therapy; 4. Multimodal Approaches for the Screening of Antistroke Agents; 5. Anti-HIV Agents; 6. Angiogenesis; 7. Sexual Dysfunction; 8. Antifertility Agents; 9. Antiobesity Agents; 10. Anticancer Agents; 11. Screening Methods for Renal and Liver Fibrosis; 12. Techniques for the Detection of Apoptosis; 13. Anticataract Agents; 14. Evaluation of Pharmacological Activity of Herbal Medicines; 15. Agents for Immune-based Disorders; 16. Antihypertensive Agents; 17. Antiglaucoma Agents; 18. Antiarrhythmics; 19. Cardiotonic Agents; 20. Antianginal Agents; 21. Antiplatelet Agents; 22. Drugs Acting on Sympathetic Nervous System; 23. Drugs Acting on Parasympathetic Nervous System; 24. Neuromuscular Blocking Agents; 25. Neuropsychopharmacology; 26. Antipsychotic Agents; 27. Antidepressant Agents; 28. Antiepileptics; 29. Anti-Alzheimers Agents; 30. Antiparkinsonian Agents; 31. Antimigraine Agents; 32. Analgesic Agents; 33. Anti-inflammatory Agents; 34. Ocular Inflammation; 35. Antiulcer Agents; 36. Agents Affecting Gut Motility; 37. Antiemetic Agents; 38. Absorption and Metabolism; 39. Hormones of Pituitary, Thyroid, Parathyroid, Adrenal Cortex, Ovary and Testes; 40. Antidiabetic Agents; 41. Diabetic Retinopathy; 42. Ocular Toxicity; 43. Phototoxicity; 44. Antiasthmatic Agents